Microchip Technology stock jumps about 4% premarket after sales forecast boost
6 January 2026
1 min read

Microchip Technology stock jumps about 4% premarket after sales forecast boost

New York, Jan 6, 2026, 08:18 EST — Premarket

  • Microchip shares rose about 4% in premarket trading after the chipmaker lifted its quarterly sales outlook. 1
  • Microchip said it expects fiscal Q3 net sales of about $1.185 billion, above its prior $1.109 billion–$1.149 billion range. 2

Microchip Technology (MCHP) shares rose 4.1% to $69.82 in premarket trading on Tuesday, after the chipmaker lifted its quarterly sales outlook. The stock ended Monday at $67.06. 3

Microchip late on Monday raised its expected fiscal third-quarter net sales to about $1.19 billion, topping its prior forecast range of $1.11 billion to $1.15 billion. The update followed signs of recovery across end markets as customers worked through excess chip stockpiles built during the pandemic, Reuters reported. 4

Chief executive Steve Sanghi said bookings were “very strong” in the December quarter and that the March-quarter starting backlog — unfilled orders on hand — began the period stronger than the prior quarter. In an SEC filing, the company also flagged lower inventory write-offs and reduced under-utilization charges — costs tied to running factories below capacity — as it prepares to ramp output. 5

The stock climbed 3.12% in Monday’s regular session, notching a second straight gain, and closed at $67.06. The shares are still about 13% below a 52-week high of $77.20, while volume on Monday ran above its 50-day average, MarketWatch data showed. 6

Analysts moved quickly to mark up their models. JPMorgan raised its price target on Microchip to $85 from $77 and kept an Overweight rating, pointing to the stronger backlog and a path to higher gross margin as factory utilization improves. 7

Microchip sells microcontrollers and analog chips used in cars, factories and consumer electronics, competing with firms such as Texas Instruments and NXP Semiconductors. For investors, the sales update is another datapoint in a wider debate over whether the industrial and automotive chip downturn is finally easing.

But the rebound case still hinges on follow-through. If customers slow orders again or push out deliveries, backlog can fade quickly, and a factory ramp risks leaving costs elevated if volumes disappoint.

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
New York, Feb 7, 2026, 07:20 EST — Market closed. Kenvue Inc shares ended Friday up 0.3% at $18.13, keeping the Tylenol maker close to the value implied by its agreed sale to Kimberly-Clark as investors headed into the weekend. With U.S. markets shut, Monday’s open is likely to be less about day-to-day company chatter and more about deal positioning. Kenvue is trading like a merger stock, where the key input is the gap between KVUE’s price and the value of what the buyer is offering. That matters now because the gap is small and jumpy. A move in Kimberly-Clark
IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next
Previous Story

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

eBay stock (EBAY) slips in premarket after 4% jump as jobs data, earnings loom
Next Story

eBay stock (EBAY) slips in premarket after 4% jump as jobs data, earnings loom

Go toTop